+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Endometriosis Treatment Market by Treatment Type, Route of Administration, End User, Distribution Channel - Global Forecast to 2030- Product Image
Endometriosis Treatment Market by Treatment Type, Route of Administration, End User, Distribution Channel - Global Forecast to 2030- Product Image
Sale

Endometriosis Treatment Market by Treatment Type, Route of Administration, End User, Distribution Channel - Global Forecast to 2030

  • PDF Icon

    Report

  • 180 Pages
  • May 2025
  • Region: Global
  • 360iResearch™
  • ID: 4989704
UP TO OFF until Dec 31st 2025
1h Free Analyst Time
Description Jump to:
1h Free Analyst Time

Speak directly to the analyst to clarify any post sales queries you may have.

The endometriosis treatment market is evolving rapidly, driven by scientific breakthroughs, changing healthcare models, and shifts in global policy. Senior leaders now face greater complexity in identifying sustainable growth opportunities and mitigating new risks within this dynamic sector.

Market Snapshot: Endometriosis Treatment Market

The Endometriosis Treatment Market grew from USD 3.05 billion in 2024 to USD 3.28 billion in 2025. It is expected to continue growing at a CAGR of 7.39%, reaching USD 4.68 billion by 2030. This growth reflects intensified investment in targeted treatments, expanded adoption of minimally invasive interventions, and a strong focus on patient-centered solutions across global regions.

Scope & Segmentation

This report examines the endometriosis treatment market through a multi-dimensional lens, capturing the full breadth of demand drivers, delivery modes, and stakeholder groups.

  • Treatment Types: Complementary therapies, hormonal therapies (aromatase inhibitors, GnRH agonists, GnRH antagonists, oral contraceptives, progestins), pain management (NSAIDs such as diclofenac, ibuprofen, naproxen; opioids like codeine, morphine), and surgical treatments.
  • Route of Administration: Injectable, oral, and topical therapies offer patients varying access options and dosing preferences.
  • End Users: Ambulatory surgical centers, hospitals, and specialty clinics each play direct roles in treatment delivery and patient engagement.
  • Distribution Channels: Hospital, online, and retail pharmacies support the availability and timely provision of endometriosis therapies across global markets.
  • Regions Analyzed: Americas (including United States, Canada, Mexico, Brazil, Argentina), Europe, Middle East & Africa (covering major EU nations, Middle Eastern economies, and African countries), and Asia-Pacific (spanning markets like China, India, Japan, Australia, Southeast Asia, and more).
  • Companies Profiled: Key industry participants analyzed include AbbVie Inc., Bayer AG, Teva Pharmaceutical Industries Ltd, Ferring International Center S.A., Mylan N.V., Sandoz International GmbH, Lupin Limited, Pfizer Inc., Sun Pharmaceutical Industries Ltd, and Dr. Reddy’s Laboratories Ltd.

Key Takeaways for Decision-Makers

  • Targeted hormonal agents and next-generation surgical procedures are reshaping therapeutic standards, creating new benchmarks for clinical outcomes and product positioning.
  • Digital health platforms enhance patient engagement through symptom tracking, telemedicine, and education, driving increased adherence and improved management of chronic symptoms.
  • Strategic partnerships between pharmaceutical and device companies, digital health providers, and advocacy groups are fostering more collaborative research and driving the pace of innovation.
  • Regional healthcare investment is accelerating in both mature and emerging markets, necessitating context-specific strategies for adoption and reimbursement success.
  • Real-world evidence collection is becoming crucial for demonstrating long-term value to payers and optimizing market access negotiations.

Tariff Impact: Navigating Policy Changes

As of January 2025, new US tariffs on imported pharmaceutical ingredients and device components are altering the landscape for manufacturers. Sourcing strategies and production footprints require realignment to manage rising input costs and supply chain uncertainties. Organizations with established domestic supply and vertically integrated operations may achieve greater price stability and reduced disruption. For others, increased costs could impact R&D prioritization and competitive differentiation, especially in new product launches or market entry strategies.

Methodology & Data Sources

This analysis combines primary interviews with market leaders, clinicians, and supply chain experts with validated secondary sources, including peer-reviewed publications and verified company data. Quantitative models triangulate data from sales, prescriptions, and clinical databases. All findings undergo review by industry experts for relevance, accuracy, and strategic appropriateness.

Why This Report Matters

  • Delivers actionable, fact-based insights for optimizing product portfolios, accelerating product development, and refining global market entry strategies.
  • Enables stakeholders to identify investment opportunities, respond to regulatory shifts, and support patient-centric care in a fluctuating policy environment.
  • Supports informed decision-making with rigorous research, comprehensive segmentation, and practical recommendations tailored for C-suite and strategy teams.

Conclusion

Transformations in the endometriosis treatment market underscore the need for agile strategies and data-driven decision-making. Senior leaders who leverage comprehensive insights are equipped to advance both organizational growth and patient outcomes amid rapid market evolution.

 

Additional Product Information:

  • Purchase of this report includes 1 year online access with quarterly updates.
  • This report can be updated on request. Please contact our Customer Experience team using the Ask a Question widget on our website.

Table of Contents

1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Market Sizing & Forecasting
5. Market Dynamics
6. Market Insights
6.1. Porter’s Five Forces Analysis
6.2. PESTLE Analysis
7. Cumulative Impact of United States Tariffs 2025
8. Endometriosis Treatment Market, by Treatment Type
8.1. Introduction
8.2. Complementary Therapies
8.3. Hormonal Therapies
8.3.1. Aromatase Inhibitors
8.3.2. Gnrh Agonists
8.3.3. Gnrh Antagonists
8.3.4. Oral Contraceptives
8.3.5. Progestins
8.4. Pain Management
8.4.1. Nsaids
8.4.1.1. Diclofenac
8.4.1.2. Ibuprofen
8.4.1.3. Naproxen
8.4.2. Opioids
8.4.2.1. Codeine
8.4.2.2. Morphine
8.5. Surgical Treatment
9. Endometriosis Treatment Market, by Route of Administration
9.1. Introduction
9.2. Injectable
9.3. Oral
9.4. Topical
10. Endometriosis Treatment Market, by End User
10.1. Introduction
10.2. Ambulatory Surgical Centers
10.3. Hospitals
10.4. Specialty Clinics
11. Endometriosis Treatment Market, by Distribution Channel
11.1. Introduction
11.2. Hospital Pharmacy
11.3. Online Pharmacy
11.4. Retail Pharmacy
12. Americas Endometriosis Treatment Market
12.1. Introduction
12.2. United States
12.3. Canada
12.4. Mexico
12.5. Brazil
12.6. Argentina
13. Europe, Middle East & Africa Endometriosis Treatment Market
13.1. Introduction
13.2. United Kingdom
13.3. Germany
13.4. France
13.5. Russia
13.6. Italy
13.7. Spain
13.8. United Arab Emirates
13.9. Saudi Arabia
13.10. South Africa
13.11. Denmark
13.12. Netherlands
13.13. Qatar
13.14. Finland
13.15. Sweden
13.16. Nigeria
13.17. Egypt
13.18. Turkey
13.19. Israel
13.20. Norway
13.21. Poland
13.22. Switzerland
14. Asia-Pacific Endometriosis Treatment Market
14.1. Introduction
14.2. China
14.3. India
14.4. Japan
14.5. Australia
14.6. South Korea
14.7. Indonesia
14.8. Thailand
14.9. Philippines
14.10. Malaysia
14.11. Singapore
14.12. Vietnam
14.13. Taiwan
15. Competitive Landscape
15.1. Market Share Analysis, 2024
15.2. FPNV Positioning Matrix, 2024
15.3. Competitive Analysis
15.3.1. AbbVie Inc.
15.3.2. Bayer AG
15.3.3. Teva Pharmaceutical Industries Ltd
15.3.4. Ferring International Center S.A.
15.3.5. Mylan N.V.
15.3.6. Sandoz International GmbH
15.3.7. Lupin Limited
15.3.8. Pfizer Inc.
15.3.9. Sun Pharmaceutical Industries Ltd
15.3.10. Dr. Reddy’s Laboratories Ltd.
16. ResearchAI
17. ResearchStatistics
18. ResearchContacts
19. ResearchArticles
20. Appendix
List of Figures
FIGURE 1. ENDOMETRIOSIS TREATMENT MARKET MULTI-CURRENCY
FIGURE 2. ENDOMETRIOSIS TREATMENT MARKET MULTI-LANGUAGE
FIGURE 3. ENDOMETRIOSIS TREATMENT MARKET RESEARCH PROCESS
FIGURE 4. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
FIGURE 5. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 6. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 7. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2030 (%)
FIGURE 8. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 9. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2030 (%)
FIGURE 10. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 11. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2030 (%)
FIGURE 12. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 13. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2030 (%)
FIGURE 14. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 15. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 16. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 17. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2030 (%)
FIGURE 18. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 19. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 20. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 21. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2030 (%)
FIGURE 22. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2024 VS 2025 VS 2030 (USD MILLION)
FIGURE 23. ENDOMETRIOSIS TREATMENT MARKET SHARE, BY KEY PLAYER, 2024
FIGURE 24. ENDOMETRIOSIS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2024
List of Tables
TABLE 1. ENDOMETRIOSIS TREATMENT MARKET SEGMENTATION & COVERAGE
TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2024
TABLE 3. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
TABLE 4. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
TABLE 5. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 6. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 7. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COMPLEMENTARY THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 8. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, BY REGION, 2018-2030 (USD MILLION)
TABLE 9. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY AROMATASE INHIBITORS, BY REGION, 2018-2030 (USD MILLION)
TABLE 10. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH AGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 11. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY GNRH ANTAGONISTS, BY REGION, 2018-2030 (USD MILLION)
TABLE 12. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL CONTRACEPTIVES, BY REGION, 2018-2030 (USD MILLION)
TABLE 13. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PROGESTINS, BY REGION, 2018-2030 (USD MILLION)
TABLE 14. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 15. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 16. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 17. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DICLOFENAC, BY REGION, 2018-2030 (USD MILLION)
TABLE 18. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY IBUPROFEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 19. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NAPROXEN, BY REGION, 2018-2030 (USD MILLION)
TABLE 20. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 21. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, BY REGION, 2018-2030 (USD MILLION)
TABLE 22. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY CODEINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 23. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY MORPHINE, BY REGION, 2018-2030 (USD MILLION)
TABLE 24. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 25. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 26. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SURGICAL TREATMENT, BY REGION, 2018-2030 (USD MILLION)
TABLE 27. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 28. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY INJECTABLE, BY REGION, 2018-2030 (USD MILLION)
TABLE 29. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ORAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 30. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TOPICAL, BY REGION, 2018-2030 (USD MILLION)
TABLE 31. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 32. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY AMBULATORY SURGICAL CENTERS, BY REGION, 2018-2030 (USD MILLION)
TABLE 33. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
TABLE 34. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY SPECIALTY CLINICS, BY REGION, 2018-2030 (USD MILLION)
TABLE 35. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 36. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HOSPITAL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 37. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ONLINE PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 38. GLOBAL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY RETAIL PHARMACY, BY REGION, 2018-2030 (USD MILLION)
TABLE 39. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 40. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 41. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 42. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 43. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 44. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 45. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 46. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 47. AMERICAS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 48. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 49. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 50. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 51. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 52. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 53. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 54. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 55. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 56. UNITED STATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
TABLE 57. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 58. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 59. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 60. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 61. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 62. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 63. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 64. CANADA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 65. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 66. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 67. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 68. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 69. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 70. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 71. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 72. MEXICO ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 73. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 74. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 75. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 76. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 77. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 78. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 79. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 80. BRAZIL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 81. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 82. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 83. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 84. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 85. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 86. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 87. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 88. ARGENTINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 89. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 90. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 91. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 92. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 93. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 94. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 95. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 96. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 97. EUROPE, MIDDLE EAST & AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 98. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 99. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 100. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 101. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 102. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 103. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 104. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 105. UNITED KINGDOM ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 106. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 107. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 108. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 109. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 110. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 111. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 112. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 113. GERMANY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 114. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 115. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 116. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 117. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 118. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 119. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 120. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 121. FRANCE ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 122. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 123. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 124. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 125. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 126. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 127. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 128. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 129. RUSSIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 130. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 131. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 132. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 133. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 134. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 135. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 136. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 137. ITALY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 138. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 139. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 140. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 141. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 142. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 143. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 144. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 145. SPAIN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 146. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 147. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 148. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 149. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 150. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 151. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 152. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 153. UNITED ARAB EMIRATES ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 154. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 155. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 156. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 157. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 158. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 159. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 160. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 161. SAUDI ARABIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 162. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 163. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 164. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 165. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 166. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 167. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 168. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 169. SOUTH AFRICA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 170. DENMARK ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 171. DENMARK ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 172. DENMARK ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 173. DENMARK ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 174. DENMARK ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 175. DENMARK ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 176. DENMARK ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 177. DENMARK ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 178. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 179. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 180. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 181. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 182. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 183. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 184. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 185. NETHERLANDS ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 186. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 187. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 188. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 189. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 190. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 191. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 192. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 193. QATAR ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 194. FINLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 195. FINLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 196. FINLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 197. FINLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 198. FINLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 199. FINLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 200. FINLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 201. FINLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 202. SWEDEN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 203. SWEDEN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 204. SWEDEN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 205. SWEDEN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 206. SWEDEN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 207. SWEDEN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 208. SWEDEN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 209. SWEDEN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 210. NIGERIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 211. NIGERIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 212. NIGERIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 213. NIGERIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 214. NIGERIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 215. NIGERIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 216. NIGERIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 217. NIGERIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 218. EGYPT ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 219. EGYPT ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 220. EGYPT ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 221. EGYPT ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 222. EGYPT ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 223. EGYPT ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 224. EGYPT ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 225. EGYPT ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 226. TURKEY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 227. TURKEY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 228. TURKEY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 229. TURKEY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 230. TURKEY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 231. TURKEY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 232. TURKEY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 233. TURKEY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 234. ISRAEL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 235. ISRAEL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 236. ISRAEL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 237. ISRAEL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 238. ISRAEL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 239. ISRAEL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 240. ISRAEL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 241. ISRAEL ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 242. NORWAY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 243. NORWAY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 244. NORWAY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 245. NORWAY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 246. NORWAY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 247. NORWAY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 248. NORWAY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 249. NORWAY ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 250. POLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 251. POLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 252. POLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 253. POLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 254. POLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 255. POLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 256. POLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 257. POLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 258. SWITZERLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 259. SWITZERLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 260. SWITZERLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 261. SWITZERLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 262. SWITZERLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 263. SWITZERLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 264. SWITZERLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 265. SWITZERLAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 266. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 267. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 268. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 269. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 270. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 271. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 272. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 273. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 274. ASIA-PACIFIC ENDOMETRIOSIS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
TABLE 275. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 276. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 277. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 278. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 279. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 280. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 281. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 282. CHINA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 283. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 284. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 285. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 286. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 287. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 288. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 289. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 290. INDIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 291. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 292. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 293. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 294. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 295. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 296. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 297. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 298. JAPAN ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 299. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 300. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 301. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 302. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 303. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 304. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 305. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 306. AUSTRALIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 307. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 308. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 309. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 310. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 311. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 312. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 313. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 314. SOUTH KOREA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 315. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 316. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 317. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 318. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 319. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS, 2018-2030 (USD MILLION)
TABLE 320. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY ROUTE OF ADMINISTRATION, 2018-2030 (USD MILLION)
TABLE 321. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY END USER, 2018-2030 (USD MILLION)
TABLE 322. INDONESIA ENDOMETRIOSIS TREATMENT MARKET SIZE, BY DISTRIBUTION CHANNEL, 2018-2030 (USD MILLION)
TABLE 323. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY TREATMENT TYPE, 2018-2030 (USD MILLION)
TABLE 324. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY HORMONAL THERAPIES, 2018-2030 (USD MILLION)
TABLE 325. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY PAIN MANAGEMENT, 2018-2030 (USD MILLION)
TABLE 326. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY NSAIDS, 2018-2030 (USD MILLION)
TABLE 327. THAILAND ENDOMETRIOSIS TREATMENT MARKET SIZE, BY OPIOIDS

Samples

Loading
LOADING...

Companies Mentioned

The companies profiled in this Endometriosis Treatment market report include:
  • AbbVie Inc.
  • Bayer AG
  • Teva Pharmaceutical Industries Ltd
  • Ferring International Center S.A.
  • Mylan N.V.
  • Sandoz International GmbH
  • Lupin Limited
  • Pfizer Inc.
  • Sun Pharmaceutical Industries Ltd
  • Dr. Reddy’s Laboratories Ltd.

Table Information

Report AttributeDetails
No. of Pages180
PublishedMay 2025
Forecast Period2025 - 2030
Estimated Market Value ( USD ) in 2025 $ 3.28 Billion
Forecasted Market Value ( USD ) by 2030 $ 4.68 Billion
Compound Annual Growth Rate7.3%
Regions CoveredGlobal
No. of Companies Mentioned11

Related Topics

Related Reports

Endometriosis Drugs Market by Drug Class, Distribution Channel, Product Type, Route of Administration, End User, Mechanism of Action - Global Forecast to 2030 - Product Image

Endometriosis Drugs Market by Drug Class, Distribution Channel, Product Type, Route of Administration, End User, Mechanism of Action - Global Forecast to 2030

  • Report
  • 190 Pages
  • Global
From
Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030 - Product Image

Endometriosis Treatment Market Size, Share & Trends Analysis Report By Treatment Type, By Drug Class, By Route Of Administration, By Distribution Channel, By Region, And Segment Forecasts, 2025 - 2030

  • Report
  • 150 Pages
  • Global
From
Endometriosis Market Report and Forecast 2025-2034 - Product Image

Endometriosis Market Report and Forecast 2025-2034

  • Report
  • 400 Pages
  • Global
From
Endometriosis Market Report by Type, Diagnosis and Treatment, End Users, and Region 2025-2033 - Product Image

Endometriosis Market Report by Type, Diagnosis and Treatment, End Users, and Region 2025-2033

  • Report
  • 142 Pages
  • Global
From
Endometriosis Drugs - Global Strategic Business Report - Product Image

Endometriosis Drugs - Global Strategic Business Report

  • Report
  • 191 Pages
  • Global
From
Copyright © 2002-2025 Research and Markets. All Rights Reserved.